Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Assembly Biosciences, Inc. (ASMB) vs REGENXBIO Inc. (RGNX)

Assembly Biosciences, Inc. and REGENXBIO Inc. are both Biotechnology companies. Assembly Biosciences, Inc. and REGENXBIO Inc. are of similar size ($487.8M and $481.7M). REGENXBIO Inc. has negative trailing earnings, so its P/E is not meaningful; Assembly Biosciences, Inc. trades at 23.2×. Assembly Biosciences, Inc. grew revenue faster over the last twelve months: 125.1% against 12.0%. Assembly Biosciences, Inc. has the higher net margin (−0.06% vs −112.6%) and the higher return on invested capital (0.00% vs 0.00%). Across the 16 metrics below, Assembly Biosciences, Inc. leads on 14 and REGENXBIO Inc. on 2.

Valuation

Metric ASMB RGNX Biotechnology median
P/E 23.21 n/m 7.88
P/S 5.96 2.24 11.47
P/B 1.46 5.45 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 1.68 2.12 10.73
Earnings yield 4.31% (51.22%) (28.84%)
Free cash flow yield (8.64%) (63.88%) (23.03%)

Profitability

Metric ASMB RGNX Biotechnology median
Gross margin 100.00% 86.38% 65.16%
Operating margin (11.75%) (94.08%) 0.00%
Net margin (0.06%) (112.58%) 0.00%
Free cash flow margin (51.53%) (143.09%) 0.00%
Return on equity (0.03%) (137.63%) (57.72%)
Return on assets (0.02%) (40.60%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric ASMB RGNX Biotechnology median
Revenue growth (TTM) 125.12% 12.00% 5.64%
EPS growth (last fiscal year) 91.78% 18.08% —
Revenue growth, 5-year CAGR 35.27% 1.97% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ASMB RGNX Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 13.99 2.86 4.73
Net debt to EBITDA 17.31 1.58 0.96

Dividend

Metric ASMB RGNX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric ASMB RGNX Biotechnology median
Market cap 481.73m 487.84m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack